PharmiWeb51m
tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – ...
PharmiWeb51m
Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences
Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...
PharmiWeb14m
ProBioGen Expands Protein and Viral Manufacturing to Drive Continued Growth
ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for ...
PharmiWeb46m
Medidata Signs Multi-Year Agreement with Bristol Myers Squibb to Extend Relationship and Continue Company’s Use of Platform
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has extended and expanded its partnership with Bristol Myers ...
PharmiWeb41m
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Galapagos NV (Euronext & NASDAQ: GLPG) (“Galapagos” or the “Company”), today announced a planned separation into two entities: a newly to be formed company (to be named at a later date, herein “SpinCo ...
PharmiWeb42m
Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San Francisco ...
PharmiWeb51m
The Brain Health Supplements Market: Driving Cognitive Well-Being
The global brain health supplements market has experienced significant growth in recent years, driven by increasing consumer awareness about cognitive health and the rising prevalence of neurological ...
PharmiWeb2h
Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000
LONDON, UK / ACCESSWIRE / January 8, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £340,000 through the issue of 100,000 new ordinary shares ("Placing ...
PharmiWeb23h
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
PharmiWeb21h
Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference
Dr. Anni Wong explains functional and aesthetic nasal corrections. FREEHOLD, NEW JERSEY / ACCESSWIRE / January 7, 2025 / In ...
PharmiWeb22h
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...
PharmiWeb3h
PhenQ Reviews: Legit Fat Burner Supplement or Scam Weight Loss Pills?
PhenQ is a natural weight management system that targets five major areas of metabolic health, providing a holistic solution for anyone trying to lose weight.  Summer season is loved and hated in ...